Clinical Trials Directory

Trials / Completed

CompletedNCT05715112

Graded Motor Imagery and Fall Risk in Older Adults

Graded Motor Imagery and Fall Risk in Older Adults: An Exploratory Study

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
St. Ambrose University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

To determine if there is any carry over effect of sensation training for the feet, officially called Graded Motor Imagery (GMI), will impact balance and fall risk factors in older individuals. This will be looked at to see if there is a difference in balance and sensation before and right after the training.

Detailed description

In order to increase acuity of body maps, various tactile and movement-based strategies have been recommended and supported for research focusing on sensory discrimination. Current evidence, specific to painful conditions related to altered cortical mapping, have shown growing evidence in reducing pain and disability. In regards to it's ability to alter foot pain in older adults and decreasing fall risk, prior conference case study and case series presentations have suggested potential clinical benefit, but it has not been formally studied. The aim of this study is to determine if a sensory discrimination training for feet in older adults can alleviate pain, improve sensory discrimination, and also decrease fall risk. Specifically, does a 20 minute training session improve pain, balance (Brief-BEST test), and sensory discrimination in individuals over 65 years of age. Secondary analysis may exam characteristics that best identify those who benefit from this training.

Conditions

Interventions

TypeNameDescription
PROCEDUREGraded Motor ImageryGMI consisting of education, sensory integration of the foot using contact, flooring samples, immersion, and two point discrimination.

Timeline

Start date
2022-08-17
Primary completion
2022-08-18
Completion
2022-08-18
First posted
2023-02-06
Last updated
2023-05-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05715112. Inclusion in this directory is not an endorsement.